These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8382471)

  • 1. Parathyroid hormone and T-cellular immunity in uremic patients in replacement dialytic therapy.
    Angelini D; Carlini A; Giusti R; Grassi R; Mei E; Fiorini I; Mazzotta L; Antonelli A
    Artif Organs; 1993 Feb; 17(2):73-5. PubMed ID: 8382471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic disturbances and levels of parathyroid hormone in uremic patients in replacement dialysis therapy.
    Angelini D; Carlini A; Mazzotta L; Mei E; Grassi R; Giusti R; Neri M; Fiorini I; Antonelli A
    Clin Nephrol; 1994 Oct; 42(4):246-50. PubMed ID: 7834917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immunity and levels of parathyroid hormone in uremic patients receiving hemodialysis.
    Griveas I; Visvardis G; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Meimaridou D; Ginikopoulou E; Sakellariou G; Fleva A; Zilidou R; Paulitou A
    Ren Fail; 2005; 27(3):275-8. PubMed ID: 15957542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory effects of secondary hyperparathyroidism on circulating CD4+ and CD8+ T-lymphocytes in chronic renal failure patients.
    El Kelany MA; Maklad SS; El Fouhil DF; El Etreby EA; Saleh LH; El Sheikh NA
    Egypt J Immunol; 2009; 16(2):71-82. PubMed ID: 22059355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enrollment parathyroid hormone level is a new marker of survival in hemodialysis and peritoneal dialysis therapy for uremia.
    Avram MM; Sreedhara R; Avram DK; Muchnick RA; Fein P
    Am J Kidney Dis; 1996 Dec; 28(6):924-30. PubMed ID: 8957048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of repetitive hemodialysis on circulating immunoreactive parathyroid hormone levels in uremic patients undergoing vitamin D (calcitriol) therapy.
    Bellazzi R; Romanini D; Bacchella L; Nai M; Aprile C; Santagostino M; De Vincenzi A
    Nephron; 1991; 57(3):273-82. PubMed ID: 2017266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
    Chudek J; Piecha G; Kokot F; Wiecek A
    J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperparathyroidism: is it really the major factor affecting glucose tolerance in uremia?
    Bergesio F; Bandini S; Cresci B; Monzani G; Rotella C; Conti A; Rosati A; Piperno R; Messeri G; Frizzi V; Salvadori M
    Miner Electrolyte Metab; 1996; 22(1-3):187-91. PubMed ID: 8676816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell activation modified by parathyroid hormone (PTH) in patients with end-stage renal disease.
    Kaneko T; Osono E; Hayama N; Lino Y; Terashi A
    Clin Nephrol; 1997 Dec; 48(6):353-8. PubMed ID: 9438093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of serum parathyroid hormone levels by intravenous alphacalcidol in uremic patients on maintenance hemodialysis. A pilot study.
    Lind L; Wengle B; Wide L; Wrege U; Ljunghall S
    Nephron; 1988; 48(4):296-9. PubMed ID: 3362275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Search for the uremic toxin. Decreased motor-nerve conduction velocity and elevated parathyroid hormone in uremia.
    Avram MM; Feinfeld DA; Huatuco AH
    N Engl J Med; 1978 May; 298(18):1000-3. PubMed ID: 205786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone and mobilization of circulating bone marrow-derived cells in uremic patients.
    Coppolino G; Bolignano D; De Paola L; Giulino C; Mannella A; Riccio M; Mascaro MA; Lombardi G; Fuiano G; Lombardi L; Buemi M
    J Investig Med; 2011 Jun; 59(5):823-8. PubMed ID: 21383630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual influence on bone metabolism in uremic patients on regular dialytic treatment.
    Luisetto G; Bertoli M
    Nephron; 1994; 67(2):150-7. PubMed ID: 8072603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone-related peptide plasma concentrations in patients on hemodialysis.
    Nordholm A; Rix M; Olgaard K; Lewin E
    Scand J Clin Lab Invest; 2014 Apr; 74(3):206-12. PubMed ID: 24456420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia.
    Quarles LD; Lobaugh B; Murphy G
    J Clin Endocrinol Metab; 1992 Jul; 75(1):145-50. PubMed ID: 1619003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function.
    Gao P; Scheibel S; D'Amour P; John MR; Rao SD; Schmidt-Gayk H; Cantor TL
    J Bone Miner Res; 2001 Apr; 16(4):605-14. PubMed ID: 11315988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism.
    Malberti F; Corradi B; Cosci P; Colecchia M; Leopardi O; Grossi L; Oldini C; Imbasciati E
    Nephrol Dial Transplant; 1996 Jan; 11(1):81-7. PubMed ID: 8649657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of parathormone levels on T-cell response in hemodialysis patients.
    Ozdemir FN; Yakupoglu U; Turan M; Arat Z; Karakayali H; Erdal R; Turan M
    Transplant Proc; 2002 Sep; 34(6):2044-5. PubMed ID: 12270308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.